Trial results show Brainsway deep TMS to be efficacious and safe for drug-resistant depression

499

A multicentre double blinded randomised controlled trial has shown Brainsway deep TMS (transcranial magnetic stimulation) to be efficacious and safe for drug-resistant depression, with a stable effect over three months of maintenance treatment.

This multicentre study examined Brainsway deep TMS as a treatment for major depressive disorder. The study included over 200 patients who were randomly assigned for real or sham Deep TMS (20 sessions) over a period of a month. Thereafter, patients underwent a maintenance period that included an additional two sessions per week over three months. 

The study found that the real deep transcranial magnetic stimulation treatment was superior to the sham treatment and induced a beneficial effect that was evident after both the acute phase and the maintenance phase. The results indicate that Brainsway deep TMS is effective and safe as a treatment for major depressive disorder.